Fundraising Fox
Corvus Pharmaceuticals
Burlingame, US · Founded 2014 · 53 employees on LinkedIn · 4 known investors
Find your way into Corvus Pharmaceuticals
Sign up to see every warm intro you have to Corvus Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Corvus Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.
Founders & leadership
Corvus Pharmaceuticals was founded in 2014 by Richard A. Miller.
Board
Investors · 4
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$87.7M disclosed across 2 rounds · 2014–2015
▶$75MraisedSep 2015 · 33 investors · Other Health CareRule 506(b)
- Leiv LeaExecutive Officer
- Elisha (Terry) P. GouldDirector
- Peter MoldtDirector
- Peter ThompsonDirector
- Richard A. MillerExecutive Officer, Director
- Offering amount
- $75M
- Amount sold
- $75M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$12.7MraisedDec 2014 · 12 investors · Other Health CareRule 506(b)
- Richard A. MillerExecutive Officer, Director
- Terry G. GouldDirector
- Leiv LeaExecutive Officer
- Peter ThompsonDirector
- Offering amount
- $33.5M
- Amount sold
- $12.7M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Corvus Pharmaceuticals went on to found or lead other companies.
In the news
Frequently asked questions
- What does Corvus Pharmaceuticals do?
- Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.
- Who founded Corvus Pharmaceuticals?
- Corvus Pharmaceuticals was founded by Richard A. Miller in 2014.
- Who are Corvus Pharmaceuticals's investors?
- Corvus Pharmaceuticals's investors include Avoro Capital Advisors, Foresite Capital, OrbiMed, Roche Venture Fund.
- How much funding has Corvus Pharmaceuticals raised?
- Corvus Pharmaceuticals has disclosed $87.7M raised across 2 rounds.
- Where is Corvus Pharmaceuticals headquartered?
- Corvus Pharmaceuticals is headquartered in Burlingame, US.